BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25333265)

  • 1. Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma.
    Qi X; Ng KT; Lian QZ; Liu XB; Li CX; Geng W; Ling CC; Ma YY; Yeung WH; Tu WW; Fan ST; Lo CM; Man K
    Oncotarget; 2014 Nov; 5(22):11103-20. PubMed ID: 25333265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation.
    Qi X; Ng KT; Shao Y; Li CX; Geng W; Ling CC; Ma YY; Liu XB; Liu H; Liu J; Yeung WH; Lo CM; Man K
    Theranostics; 2016; 6(11):1934-46. PubMed ID: 27570561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence.
    Qi X; Ng KT; Lian Q; Li CX; Geng W; Ling CC; Yeung WH; Ma YY; Liu XB; Liu H; Liu J; Yang XX; Lo CM; Man K
    Theranostics; 2018; 8(1):212-222. PubMed ID: 29290803
    [No Abstract]   [Full Text] [Related]  

  • 4. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
    Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
    Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.
    Qi J; Zhao P; Li F; Guo Y; Cui H; Liu A; Mao H; Zhao Y; Zhang X
    Int J Clin Exp Pathol; 2015; 8(5):4963-71. PubMed ID: 26191189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.
    Zhang S; Liang X; Zheng X; Huang H; Chen X; Wu K; Wang B; Ma S
    Int J Clin Exp Pathol; 2014; 7(5):2079-90. PubMed ID: 24966916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
    Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
    Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
    Pang YY; Li JD; Gao L; Yang X; Dang YW; Lai ZF; Liu LM; Yang J; Wu HY; He RQ; Huang ZG; Xiong DD; Yang LH; Shi L; Mo WJ; Tang D; Lu HP; Chen G
    Cancer Med; 2020 Nov; 9(21):8004-8019. PubMed ID: 32931665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of promoter and expression silencing of GPX3 gene in hepatocellular carcinoma tissue.
    Cao S; Yan B; Lu Y; Zhang G; Li J; Zhai W; Guo W; Zhang S
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):198-204. PubMed ID: 25445749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
    Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
    J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
    Lu Y; Zhou J; Zhang J; Wang Z; Yu Y; Miao M; Yao Q
    Biomed Pharmacother; 2019 Dec; 120():109532. PubMed ID: 31605953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.